Can a simple phone call keep cirrhosis patients out of the hospital?
NCT ID NCT06174272
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests an intensive monitoring program for people with cirrhosis and severe swelling (fluid overload) after they leave the hospital. Participants receive a digital scale, educational materials, weekly phone calls, and a follow-up appointment with a liver specialist. Researchers want to see if this program is feasible and if it reduces hospital readmissions, kidney injury, and fluid buildup compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- transitional care program (intensive monitoring with digital scale, educational binder, phone calls, and follow-up appointments)
- What this could lead to
- If successful, this program could reduce hospital readmissions and complications for cirrhosis patients with fluid overload.
- What could go wrong
- This is a very small pilot study (20 participants) focused on feasibility, not effectiveness. The program may not show clear benefits or may be too resource-intensive to scale.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Penn State Milton S. Hershey Medical Center
RECRUITINGHershey, Pennsylvania, 17033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- New study tracks blood sugar in liver disease patients on common drug
- New drug aims to stop liver failure in NASH patients
- Can spleen surgery save kidneys in liver patients?
- Spleen surgery may change fat levels in liver patients – study to watch